Move will speed up development of LSD-based drug as a treatment for generalized anxiety disorder.
Source: https://www.marketwatch.com/story/mindm ... topstories
MindMed’s stock soars 44% after FDA grants breakthrough designation to LSD therapy for a form of anxiety
